PET/CT scan test for tumors using a special tracer
This Phase 3 study tests whether a PET/CT scan using a tracer called 18F-fluorocholine can better identify tumors. It may help doctors more accurately find and characterize tumors to guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your doctor is currently managing your care and you can be referred to this study
- You can understand the study and sign written consent
- You can lie still (on your back or stomach) for up to about 30 minutes and get an IV placed for the tracer injection
- You have a known or suspected tumor that is expected to “light up” on this specific tracer scan (18F-fluorocholine-avid), based on your doctors’ information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how useful an F-choline PET scan is for finding information in people with known or suspected conditions. It may help doctors decide what to look for or how to guide care in “new and emerging” situations.
This trial studies how a special PET/CT scan (using 18F-DCFPyL) helps evaluate prostate cancer that is either high-risk at diagnosis or has come back based on PSA blood tests. It may help your care team better stage (map) the cancer and guide next steps.
This study uses a special imaging scan (PET/MR) with a tracer called fluorocholine to see if it can help evaluate breast cancer before treatment or before surgery. It is for women who are newly diagnosed with breast cancer and will either have chemotherapy before surgery or go straight to surgery.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
This early study uses a special PET/CT scan to see how much a specific cancer-related protein (PARP-1) is present in pheochromocytoma and paraganglioma. It may help doctors understand the biology of these tumors and how useful this scan could be in the future.
This Phase 1 study tests a new PET/CT imaging tracer to see how well it can detect breast cancer spots in the body. It may help doctors learn where breast cancer is and how imaging could work better in the future.
Hear when a new Fluorocholine PET/CT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.